Rossella Rota - Concepedia

Author

Rossella Rota

Also Known As

Maurizio C Capogrossi, Maurizio Colognesi Capogrossi, Maurizio Pesce, R Rota, R. ROTA, R. Rota, Riccardo Rota, Rosa Rota, Rossella Rota, Rossella Rota (559755)

187

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Bambino Gesù Children's Hospital Istituti di Ricovero e Cura a Carattere Scientifico Sapienza University of Rome University of Pavia University of Naples Federico II

About

Rossella Rota is an author at Bambino Gesù Children's Hospital specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.2K
2	Natural Sciences	3	3	252
3	Engineering	1	1	72
4	Social Sciences	1	1	29
5	Biochemistry	1	1	28

Rossella Rota

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability Berkley E. Gryder, Marielle E. Yohe, Hsien-Chao Chou, Cancer Discovery	2017	317
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial Olga Vaccaro, Maria Masulli, Antonio Nicolucci, The Lancet Diabetes & Endocrinology Diabetes ManagementCardiovascular DiseaseDiabetesPharmacologyCardiovascular Pharmacology	2017	285
Down-regulation of RNA Editing in Pediatric Astrocytomas Caterina Cenci, Rita Barzotti, Federica Galeano, Journal of Biological Chemistry PathologyCell CycleGliomaTumor BiologyNeuro-oncology	2008	189
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma Berkley E. Gryder, Silvia Pomella, Carly M. Sayers, Nature Genetics Histone ModificationsChromatinChromatin StructureChromatin RemodelingNatural Sciences	2019	173
Chemical genomics reveals histone deacetylases are required for core regulatory transcription Berkley E. Gryder, Lei Wu, Girma M. Woldemichael, Nature Communications	2019	148
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS Roberta Ciarapica, Elena Carcarino, Laura Adesso, BMC Cancer	2014	72
Brain Targeting by Liposome–Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells Antonietta Arcella, Sara Palchetti, Luca Digiacomo, ACS Chemical Neuroscience NanoparticlesNanotherapeuticsEngineeringBrain TargetingImmunotherapeutics	2018	72
Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells Annalisa Romanelli, Giulia Stazi, Rossella Fioravanti, ACS Medicinal Chemistry Letters	2020	72
The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx) Roberta Ciarapica, Maria De Salvo, Elena Carcarino, Oncogene	2013	71
MMSET Is Highly Expressed and Associated with Aggressiveness in Neuroblastoma Heidi Rye Hudlebusch, Julie Skotte, Eric Santoni‐Rugiu, Cancer Research	2011	69

Page 1